Document Detail


A liquid chromatographic method for quantifying unbound micafungin in human plasma and the relationship between the concentrations of unbound and total micafungin in plasma.
MedLine Citation:
PMID:  23208119     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This report describes a modified method for the quantitative determination of unbound micafungin (MCFG) in human plasma that is unrelated to chemical methods currently in use, and the relationship between the concentration of unbound and total MCFG in plasma of the patients. The mobile phase consisted of 50 mM phosphate buffer:tetrahydrofuran (65:35,v/v). Samples were fractionated on a C-18 column. The fluorescence detection wavelengths of excitation and emission were set at 273nm and 464nm, respectively. The retention times of MCFG and 1-hydroxy-2-naphtoeic acid (internal standard: IS) were 10.5 min and 7.3 min, respectively. For each concentration of MCFG/IS, the peak height ratio on a 5-point calibration curve was linear from 0.004 to 0.08 μg/mL (r=0.999, P<0.001). In addition, the concentrations of unbound and total MCFG were measured in the plasma of 11 patients treated with MCFG for fungal infection. In total, 99 samples were collected. The concentration of unbound and total MCFG in plasma correlated with one another (r =0.896, P<0.001). These concentrations were not affected by serum albumin, total bilirubin, blood urea nitrogen, or Creatinine clearance. There were small differences of [fu (unbound MCFG/total MCFG)×100%] in the every term after start of treatment of MCFG. Further, there was no difference in the unbound and total concentration of MCFG in plasma between the effective group and the ascertained effectiveness group. Conclusion: The concentration of MCFG in plasma could be used as an indicator of clinical effect as a substitute for the concentration of unbound MCFG in plasma.
Authors:
Kumiko Noda; Toshinori Yokoyama; Yasushi Akiyama; Koji Tadano
Related Documents :
23929729 - Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurre...
24604569 - Monitoring oxycodone use in patients with chronic pain: analysis of oxycodone and metab...
23618499 - Maternal plasma 25-hydroxyvitamin d levels, angiogenic factors, and preeclampsia.
24592919 - Coagulation assays and plasma fibrinogen concentrations in real-world patients with atr...
23575879 - Association of circulating factor seven activating protease (fsap) and of oral omega-3 ...
24009749 - The effect of lutein supplementation on blood plasma levels of complement factor d, c5a...
16461559 - Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in ...
3555119 - Interleukin-1 decreases renal sodium reabsorption: possible mechanism of endotoxin-indu...
23553159 - An increase in renal dopamine does not stimulate natriuresis after fava bean ingestion.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-04
Journal Detail:
Title:  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan     Volume:  -     ISSN:  1347-5231     ISO Abbreviation:  Yakugaku Zasshi     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0413613     Medline TA:  Yakugaku Zasshi     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Practical Pharmacy, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analyzing murine schwann cell development along growing axons.
Next Document:  Percutaneous release, open surgery, or corticosteroid injection, which is the best treatment method ...